F.‐J. Kaup

The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies

Stefanie Gierer, Stephanie Bertram, F.‐J. Kaup et al. · Journal of Virology · 2013 · 350 citations · Full text

Hcov-emc Infection, Viral Pathogenesis, Immunology +16

Severe Fever with Thrombocytopenia Virus Glycoproteins Are Targeted by Neutralizing Antibodies and Can Use DC-SIGN as a Receptor for pH-Dependent Entry into Human and Animal Cell Lines

Heike Hofmann, Xingxing Li, Xiao‐Ai Zhang et al. · Journal of Virology · 2013 · 165 citations · Full text

Ph-dependent Entry, Thrombocytopenia Syndrome Virus, Molecular Virology +14

Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion.

Ute Modlich, F.‐J. Kaup, Hellmut G. Augustin · PubMed · 1996 · 133 citations

Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors.

Klaus Überla, Christiane Stahl‐Hennig, D Böttiger et al. · Proceedings of the National Academy of Sciences · 1995 · 130 citations · Full text

Immunology, Antiviral Drug, Immunotherapy +18

Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression

Kerstin Gnirß, Annika Kühl, Christina B. Karsten et al. · Virology · 2012 · 107 citations

Molecular Virology, Cathepsins B, Pathogenesis +9